Regulation of glucose and glutamine metabolism to overcome cisplatin resistance in intrahepatic cholangiocarcinoma

Intrahepatic cholangiocarcinoma (ICC) is a bile duct cancer and a rare malignant tumor with a poor prognosis owing to the lack of an early diagnosis and resistance to conventional chemotherapy. A combination of gemcitabine and cisplatin is the typically attempted first-line treatment approach. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, So Mi, Kim, Jueun, Lee, Ji-Yeon, Lee, Jung-Shin, Lee, Ji Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Biochemistry and Molecular Biology 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689087/
https://www.ncbi.nlm.nih.gov/pubmed/37401237
http://dx.doi.org/10.5483/BMBRep.2023-0029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689087/
https://www.ncbi.nlm.nih.gov/pubmed/37401237
http://dx.doi.org/10.5483/BMBRep.2023-0029

Ejemplares similares